Sign in
4

Changes in Ownership

UNITED THERAPEUTICS Corp Filed Acc 0001636178-26-000003

CFO AND TREASURER sold 10,000 shares at an average $527.48 ($5,274,802)

  • CFO AND TREASURER acquired 10,000 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

EDGEMOND JAMES · CFO AND TREASURER

Table I: Non-derivative

18 lines
Date Transaction Shares Price Value Owned after D/I
2026-03-23 Exercise or conversion : show line 1 in the form 10b5-1 +10,000 $135.42 $1,354,200 28,876 D
2026-03-23 Sale : show line 2 in the form 10b5-1 −200 $518.28 $103,657 28,676 D
2026-03-23 Sale : show line 3 in the form 10b5-1 −640 $519.30 $332,354 28,036 D
2026-03-23 Sale : show line 4 in the form 10b5-1 −875 $520.62 $455,539 27,161 D
2026-03-23 Sale : show line 5 in the form 10b5-1 −905 $521.47 $471,927 26,256 D
2026-03-23 Sale : show line 6 in the form 10b5-1 −200 $522.36 $104,473 26,056 D
2026-03-23 Sale : show line 7 in the form 10b5-1 −440 $524.20 $230,648 25,616 D
2026-03-23 Sale : show line 8 in the form 10b5-1 −320 $525.37 $168,118 25,296 D
Open-market sales · 10,000 sh · avg $527.48 · $5,274,802

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-03-23 Exercise or conversion : show line 19 in the form 10b5-1 Stock Option −10,000 152,500 D
Loading xslF345X06/primarydocument.xml…